Editor’s Note:
ER-positive, tamoxifen-nonresponsive breast cancer
is a bad disease
- Select publications

Interviews
Kevin R Fox, MD
- Select publications

William J Gradishar, MD
- Select publications

Professor John F R Robertson,
MB, ChB, BSc, MD
- Select publications

Patrick I Borgen, MD
- Select publications

Highlights from a Miami Breast Cancer Conference Tumor Panel Discussion on Adjuvant Systemic Therapy

Adjuvant Trastuzumab for Patients with HER2-Positive Disease
- Select publications

Adjuvant Endocrine Therapy
for Patients with ER- and/or
PR-Positive Disease
- Select publications

Selection and Schedule of Adjuvant Chemotherapy
- Select publications

CME Information

Faculty Disclosures

Editor's Office